Brett J. Hoskins

Dr. Brett J. Hoskins

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Indiana University School of Medicine, Indianapolis, Indiana, USA
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Pediatric Annals
Verified
Journal Article
Closed access
PDF file
Brett J. HoskinsBrett J. Hoskins
Brett J. Hoskins
NKNicholas Keeven
Nicholas Keeven
MDMary Dang
Mary Dang
EKEmily Keller
Emily Keller
RNRajeev Nagpal
Rajeev Nagpal
We describe the case of a child with progressive abdominal pain and rash admitted to a large tertiary children's hospital in the Chicago metropolitan area and subsequently found to have immunoglobulin A (IgA) vasculitis and coronavirus disease 2019 (COVID-19). This patient presented with abdominal pain, purpuric lesions, hematochezia, increasingly elevated D-dimer, and abnormal inflammatory markers on laboratory evaluation. To the best of our knowledge, this article describes the only reported pediatric case of COVID-19 associated with IgA vasculitis. [ Pediatr Ann . 2021;50(1):e44–e48.]

17 February 2025 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
EAErik Almazan
Erik Almazan
TLTom Z. Liang
Tom Z. Liang
BHBrenna Hohl
Brenna Hohl
Brett J. HoskinsBrett J. Hoskins
Brett J. Hoskins
JBJacqueline E. Birkness‐Gartman
Jacqueline E. Birkness‐Gartman
KNKenneth Ng
Kenneth Ng

24 February 2022 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
Brett J. HoskinsBrett J. Hoskins
Brett J. Hoskins
EAErik Almazan
Erik Almazan
DMDouglas Mogul
Douglas Mogul
KNKenneth Do Ng
Kenneth Do Ng

17 May 2023 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
Brett J. HoskinsBrett J. Hoskins
Brett J. Hoskins
EAErik Almazan
Erik Almazan
BHBrenna Hohl
Brenna Hohl
KNKenneth Ng
Kenneth Ng

12 March 2025 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
Brett J. HoskinsBrett J. Hoskins
Brett J. Hoskins
Deep enteroscopy, encompassing push enteroscopy (PE) and balloon-assisted enteroscopy (BAE), has revolutionized the diagnosis and treatment of pediatric small bowel disorders. This review examines the evolving role of these techniques in managing conditions such as obscure gastrointestinal bleeding, Crohn's disease, polyposis syndromes, strictures, and small bowel tumors. While PE is effective for both diagnostic and therapeutic interventions in the proximal small bowel, its limited insertion depth has driven the adoption of BAE techniques. These include single-balloon enteroscopy (SBE) and double-balloon enteroscopy (DBE), which provide deeper and more comprehensive access. Both BAE modalities offer greater insertion depth and stability, enabling advanced therapeutic interventions such as polypectomy, stricture dilation, and hemostasis. Pediatric-specific data demonstrate high diagnostic yields for BAE, with comparable outcomes between SBE and DBE. These techniques have proven safe across diverse indications, though younger children may experience slightly higher complication rates due to anatomical considerations. Despite these advancements, challenges persist, including a limited evidence base in pediatrics, barriers to training, and the need for standardized protocols. Additionally, emerging innovations such as artificial intelligence offer opportunities to enhance diagnostic accuracy and procedural efficiency. Comparative analyses of PE, BAE, and capsule endoscopy are necessary to refine procedural selection and optimize outcomes in pediatric patients. Furthermore, structured pediatric training programs and simulation-based learning could address competency gaps, ensuring safe and effective application of these techniques. By addressing current research gaps, embracing technological advancements, and tailoring approaches to pediatric populations, deep enteroscopy can continue to transform the management of small bowel disorders in children.

12 August 2025 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Open access
Brett J. HoskinsBrett J. Hoskins
Brett J. Hoskins
JGJared M. Grabau
Jared M. Grabau
DRDouglas K. Rex
Douglas K. Rex
Objectives: Endoscopic mucosal resection (EMR) is well established in adult gastroenterology but remains underutilized in pediatrics due to limited data, training opportunities, and equipment. This study presents a 10‐year, single‐center experience with conventional hot and cold snare EMR, band‐assisted (B‐EMR), and underwater EMR (U‐EMR) techniques in pediatric patients. Methods: A retrospective review was conducted of all EMR procedures performed in patients under 21 years of age between 2015 and 2025 at a tertiary care children's hospital. Data on patient demographics, lesion characteristics, procedural details, pathology, and outcomes were collected and analyzed descriptively. Results: Twenty EMRs were performed in 18 patients (mean age 17.1 years, range 3–20). The most common underlying diagnoses included familial adenomatous polyposis ( n = 7), sporadic mucosal polyps ( n = 4), subepithelial lesions ( n = 4), juvenile polyposis syndrome ( n = 2), Peutz‐Jeghers syndrome ( n = 1), and Lynch syndrome ( n = 1). Lesions ranged from 6 to 80 mm and were located throughout the gastrointestinal tract, most commonly in the colon ( n = 9), duodenum ( n = 5), and esophagus ( n = 3). Techniques included hot snare EMR ( n = 9), cold snare EMR ( n = 6), B‐EMR ( n = 4), and U‐EMR ( n = 1). Complete resection was achieved in 95% of cases, with one incomplete resection requiring surgical management for adenocarcinoma. B‐EMR was safely applied to subepithelial lesions. No delayed complications occurred. Conclusions: EMR is feasible, safe, and effective in pediatric patients for both mucosal and subepithelial lesions. Broader adoption in pediatric practice will require expanded training, multidisciplinary collaboration, and development of pediatric‐specific guidelines. These findings support EMR as a valuable therapeutic option in complex pediatric gastrointestinal disease.